These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 23776159)
1. Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete. Jang KH; Nam SJ; Locke JB; Kauffman CA; Beatty DS; Paul LA; Fenical W Angew Chem Int Ed Engl; 2013 Jul; 52(30):7822-4. PubMed ID: 23776159 [TBL] [Abstract][Full Text] [Related]
2. Anthracimycin B, a Potent Antibiotic against Gram-Positive Bacteria Isolated from Cultures of the Deep-Sea Actinomycete Rodríguez V; Martín J; Sarmiento-Vizcaíno A; de la Cruz M; García LA; Blanco G; Reyes F Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30366404 [TBL] [Abstract][Full Text] [Related]
3. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis. Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397 [TBL] [Abstract][Full Text] [Related]
5. [Determining the sensitivity of anthrax bacteria to antibiotics for its differentiation from the antibiotic sensitivity of spore-forming saprophytes]. Proskurina VA; Buravtseva NP; Iaroshchuk VA; Neliapin NM; Eremenko EI Antibiot Khimioter; 1992 Feb; 37(2):23-5. PubMed ID: 1514849 [No Abstract] [Full Text] [Related]
6. Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms. Dassanayake MK; Khoo TJ; An J Ann Clin Microbiol Antimicrob; 2021 Dec; 20(1):79. PubMed ID: 34856999 [TBL] [Abstract][Full Text] [Related]
8. Lysins as a powerful alternative to combat Bacillus anthracis. Nakonieczna A; Abramowicz K; Kwiatek M; Kowalczyk E Appl Microbiol Biotechnol; 2024 Jun; 108(1):366. PubMed ID: 38850320 [TBL] [Abstract][Full Text] [Related]
9. Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model. Heine HS; Purcell BK; Bassett J; Miller L; Goldstein BP Antimicrob Agents Chemother; 2010 Mar; 54(3):991-6. PubMed ID: 20047912 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare. Jones ME; Goguen J; Critchley IA; Draghi DC; Karlowsky JA; Sahm DF; Porschen R; Patra G; DelVecchio VG Clin Microbiol Infect; 2003 Sep; 9(9):984-6. PubMed ID: 14616693 [TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey. Esel D; Doganay M; Sumerkan B Int J Antimicrob Agents; 2003 Jul; 22(1):70-2. PubMed ID: 12842331 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Bacillus anthracis in an endemic area. Bakici MZ; Elaldi N; Bakir M; Dökmetaş I; Erandaç M; Turan M Scand J Infect Dis; 2002; 34(8):564-6. PubMed ID: 12238569 [TBL] [Abstract][Full Text] [Related]
13. Using old antibiotics to treat ancient bacterium-β-lactams for Bacillus anthracis meningitis. Sittner A; Ben-Shmuel A; Glinert I; Bar-David E; Schlomovitz J; Kobiler D; Weiss S; Levy H PLoS One; 2020; 15(2):e0228917. PubMed ID: 32053632 [TBL] [Abstract][Full Text] [Related]